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Aberrant activation of Wnt/β-catenin signaling plays an important role in the development of colon cancer. HS7 is an active
fraction extracted from Taiwanofungus camphoratus, which had been widely used as complementary medicine for Taiwan cancer
patients in the past decades. In this study, we demonstrated the eﬀects of HS7 on the growth inhibition, apoptosis induction, and
Wnt/β-cateninsignalingsuppressioninhumancoloncancercells.HS7 signiﬁcantlyinhibited proliferationofHT29,HCT116,and
SW480 colon cancer cells in a dose- and time-dependent manner. The apoptosis induction was evidenced by DNA fragmentation
and subG1 accumulation, which was associated with increased Bax/Bcl-2 ratio, activation of caspase-3 and cleavage of PARP. By
using Tcf-dependent luciferase activity assay, HS7 was found to inhibit the β-catenin/Tcf transcriptional activities. In addition,
HS7 strongly suppressed the binding of Tcf complexes to its DNA-binding site shown in electrophoretic mobility shift assay. This
inhibition was further conﬁrmed by the decreased protein levels of Tcf-4 and β-catenin. The β-catenin/Tcf downstream target
genes, such as survivin, c-myc, cyclin D1, MMP7,a n dMT1-MMP involved in apoptosis, invasion, and angiogenesis were also
diminished as well. These results indicate that Taiwanofungus camphoratus may provide a beneﬁt as integrative medicine for the
treatment of colon cancer.
1.Introduction
As the diet and life styles of the industrialized Western
countries are adopted globally, the incidence of colorectal
cancer (CRC) is increasing worldwide [1]. It becomes
a second most common cancer and the third leading
cause of cancer death in Taiwan. Fifty percent of patients
diagnosed with CRC will eventually die from the disease,
and less than 10% of patients with metastatic CRC survived
more than 5 years [2]. Lots of studies have been carried
on to search for eﬀective therapeutics targeting on the
molecular pathogenesis of CRC. Nowadays, several eﬀective
chemotherapeutics and molecular targeting agents, such
as bevacizumab and cetuximab, which target VEGFR and
EGFR, respectively, had been introduced into current colon
cancer therapy. However, most of the advanced patients
encountered inevitable relapse. Searching for new therapeu-
tics targeting on other molecular pathway to improve the
clinical outcome is urgently needed.
The Wnt/β-catenin signaling pathway plays an impor-
tant role in both embryogenesis and tumorigenesis. Most
sporadic colorectal cancer (CRC) and familial adenomatous
polyposis (FAP) have mutated adenomatous polyposis coli
(APC) gene. Normal APC protein could downregulate the
Wnt signaling pathway through its binding to β-catenin and
Axin, but most mutated APC proteins in colorectal tumors
fail to inhibit Wnt signaling, leading to the overproliferation
of tumor cells [3]. Recent researches have implicated that
the aberrant Wnt/β-catenin signaling pathway plays an
important role in several common cancers including liver,2 Evidence-Based Complementary and Alternative Medicine
lung,and colorectalcancers[4].The currentsignaling model
of Wnt/β-catenin indicates that the binding of Wnt protein
to its transmembrane-frizzled receptor could stabilize β-
catenin by inhibiting the activity of the serine/threonine
kinase GSK-3β [5]. The GSK-3β kinase associated with β-
catenin in a multiprotein complex, which is composed of
the adenomatous polyposis coli tumor suppressor protein
APC, axin, conductin, and protein phosphatase 2A. GSK-
3β phosphorylates the NH2 terminus of β-catenin and
therebyinducesitsdegradationviatheubiquitin-proteasome
pathway [6]. In response to Wnt signaling, GSK-3β is
inhibited by disheveled proteins, and, therefore, β-catenin
could escape from phosphorylation. The unphosphorylated
β-catenin accumulatesin thecytoplasmandtranslocates into
the nucleus. In the nucleus, β- c a t e n i np l a y sa sat r a n s c r i p -
tional activator in association with T-cell factor/lymphocyte
enhancer factor (Tcf/Lef) family and other transcriptional
cofactors [7], by which a variety of target genes including
c-myc, cyclin D1,a n dsurvivin were subsequently activated
[8, 9]. Dysregulation of β-catenin signaling is believed to
be critical to the early stages of human sporadic colorectal
carcinogenesis [10]. The Wnt/β-catenin signaling pathway
hadbeenproposedasatargetfordrugdiscovery[11].Several
substances had been studied for the ability to inhibit this
aberrantly activated Wnt/β-catenin signaling in colorectal
cancer [12, 13]. To ﬁnd clinically feasible natural substances
with this activity but less toxicity is warranted.
T. camphoratus (syn. Antrodia camphorata)i saGano-
derma-like fungus, which belongs to family of Polyporaceae,
Basidiomycota, and grows in a unique host, the endemic
perennial tree Cinnamomun kanehirae (Bull camphor tree)
in Taiwan. In the past ﬁfteen years, T. camphoratus has been
showntoexertantioxidant[14],anti-inﬂammatory [15],and
immunomodulatory activities [16] in a variety of experi-
ments. On the other hand, many studies have demonstrated
that T. camphoratus exerted multiple biological activities
againstvariouscancercellsintheaspectsofantiproliferation,
apoptosis induction, anti-invasion, and antimetastasis [17–
19]. Recently, we have isolated the most potent fraction
HS7 from the n-hexane extract of T. camphoratus by silica
gel chromatography, which appears to possess signiﬁcant
antiproliferative activities against a panel of human cancer
cell lines, including lung adenocarcinoma cells (CL1-0),
prostate cancer cells (PC3), and hepatocellular carcinoma
cells (Hep3B & Huh7). However, the anticancer eﬀects of
HS7 on colon cancer cells and the underlying molecular
mechanisms remain unclear.
The aim of this study was to address whether the active
fraction HS7 isolated from T. camphoratus could inhibit the
proliferation of human colon cancer cells as well as the
Wnt/β-catenin signaling pathway. These data may provide
important insight for the use of T. camphoratus as a potential
complementary therapeutic agent for colorectal cancer.
2.Methodsand Materials
Propidium iodide (PI) and Sulforhodamine B (SRB) were
purchased from Sigma-Aldrich Co. (St. Louis, Mo). Trizol
reagent, fetal bovine serum (FBS), and trypsin-EDTA (T/E)
were obtained from Gibco BRL Life Technologies (Grand
Island, NY). The QIAGEN One-tube RT-PCR system and
Annexin-V/FITC Apoptosis Kits were obtained from Qiagen
Inc. (Valencia, CA) and R&D Systems, Inc. (Minneapolis,
MN), respectively. Lipofectamine was purchased from Invit-
rogen (Rockville, MD). An enhanced chemiluminescence
(ECL) kit was purchased from Amersham Corp. (Arlington
Heights, IL). Anti-Tcf-4 and anti-active-β-catenin anti-
bodies were purchased from Chemicon International, Inc.
(Temecula, CA). Anti-Bcl2, anti-Bax, anti-β-catenin, and
anti-survivin antibodies were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA), and anticleaved
caspase-3 and anti-PARP antibodies were purchased from
Cell Signaling Technology, Inc. (Beverly, MA). The plas-
mids TOPﬂash and FOPﬂash were purchased from Upstate
Biotechnology, Inc. (Lake Placid, NY). NE-PER nuclear
extraction reagent was purchased from Thermo Fisher
Scientiﬁc Inc. (Rockford, IL). The electrophoretic-mobility
shift assay (EMSA) kits were purchased from Panomics, Inc.
(Fremont, CA).
2.1. Cell Lines and Cultures. The HT-29, HCT116, and
SW480 human colorectal cancer cell lines were obtained
from American Type Culture Collection (ATCC). All of
the cell lines were maintained in RPMI-1640 culture
medium supplementedwith 10% fetal bovine serumand 1%
Penicillin-Streptomycin-Glutamine (100x) liquid (Gibco).
Cells were cultured in an incubator with humidiﬁed air at
37◦Cw i t h5 %C O 2. The cells were regularly seeded into T-
75 ﬂasks with media changes every 3 days. For experiments,
cells were grown to 70% conﬂuence, trypsinized with 0.25%
trypsin-EDTA, and then replated at a density of 105 per ml
in culturedmedia. Asan untreated solvent control, cellswere
treated with DMSO at a ﬁnal concentration of <0.05%.
2.2. Preparation of Active Fraction HS7 from T. camphoratus.
The fruiting body-like T. camphoratus (voucher number TC-
2004-09-001) was cultivated and provided by Well Shine
Biotechnology Development Co. (Taipei, Taiwan). Brieﬂy,
air-dried ground powder of the cultivated T. camphoratus
was extracted exhaustively with n-hexane and then separated
by silica gel chromatography. Eight fractions (HS1 to HS8)
were obtained, and the seventh (HS7) appeared to be the
most active fraction ongrowthinhibition against a screening
panel of cancer cell lines.
2.3.SulforhodamineB(SRB)Assay. Accordingtothemethod
described by Vichai and Kirtikara [20], sulforhodamine
B (SRB) dye-binding assay was used to determine the
antiproliferative eﬀects of HS7 on colon cancer cells. HS7
were dissolved in DMSO before diluting with medium to
a ﬁnal DMSO concentration of <0.05%. The cancer cells
were seeded into 96-well plates at density of 3000 cells/well.
After 24 hours, the medium was replaced with fresh medium
containing diﬀerent doses of HS7 and then incubated for
another 48 hours. The cells were then ﬁxed by TCA (10%)
andincubatedfor1hourat4◦C.Theplat esw er ethenwas hedEvidence-Based Complementary and Alternative Medicine 3
5 times with tap water and air dried. The dried plates were
stained with 100μL of 0.4% (w/v) SRB prepared in 1%
(v/v) acetic acid for 10 minutes at room temperature. The
plates were washed 4 times with 1% acetic acid to remove
unbound dye and then air dried until no moisture was
visible. The bound dye was dissolved in 20mmol/L Tris base
(100μL/well) for 5 minutes on a shaker. Optical densities
were measured on a microplate reader (Molecular Devices,
Sunnyvale, CA) at 562nm.
2.4. Flow Cytometric Assessment of Apoptosis Using Annexin
V Assay. Apoptosis was determined by using a commer-
cially available annexin V apoptosis detection kit and ﬂow
cytometry. Following treatment of the colon cancer cells (1
× 106 cells/mL) with diﬀerent doses of HS7 for 48 hours,
cells were harvested and washed twice with 2mL of ice-cold
phosphate-buﬀered saline (PBS). Cells were then incubated
with 100μL of HEPES buﬀer containing 2μLo fﬂ u o r e s c e i n
isothiocyanate- (FITC-) conjugated annexin V and 2μLo f
propidiumiodide(PI)for15minutes. Afterwashing thecells
of excess reagents, 400μLo fb i n d i n gb u ﬀer was added. The
stained cells were immediately analyzed with a FACSCalibur
ﬂow cytometer. Approximately 10,000 counts were made for
each sample. The percentage distributions of apoptotic cells
were calculated by CellQuest software (Becton, Dickinson
and Co., San Jose, CA).
2.5. Cell Cycle Analysis. Propidium iodide (PI) staining
and ﬂow cytometry were used to determine the cell cycle
distribution. Cells were treated with diﬀerent doses of HS7
for 48 hours at 37◦C. The treated cells were washed with
5mLPBSandthenharvestedusing0.25%TrypsinEDTAand
suspended in RPMI at a concentration of 1 × 106 cells/tube.
After being washed with PBS and centrifuged at 1200rpm
at 4◦C for 5min, cells were resuspended in 500μLP B Sa n d
ﬁxed with 4.5mL 70% ethanol followed by gentle vortexing.
Cells were allowed to stand overnight at −20◦C. Fixed cells
were spun down and washed with 5mL PBS. The cells were
then suspended in 500μLP I( 2μg/mL)/Triton X-100 (0.1%
v/v) staining solution with RNase A (200μg/mL) in the dark
andthenanalyzedbyaﬂowcytometer.Approximately10,000
counts were made for each sample. The percentage distribu-
tionsofapoptoticcellswerecalculatedbyCellQuestsoftware.
2.6. DNA Fragmentation Analysis. The HT29 cells treated
with diﬀerent doses of HS7 were harvested, washed twice
with PBS, and then lysed in 100mL oflysis buﬀerfor3 hours
at56◦C.ThecellsweretreatedwithRNaseAforanotherhour
at 37◦C. The DNA was extracted by phenol: chloroform:
isoamyl alcohol (v/v/v, 25:24:1) and analyzed by 1.8%
agarose gel electrophoresis. Approximately 2μgo fD N Aw a s
loaded into each well. The agarose gels were then run at 50V
for 90 minutes in Tris-borate/EDTA electrophoresis buﬀer
(TBE). The bands were visualized under ultraviolet (UV)
light and photographed.
2.7. β-Catenin/Tcf Transcription Reporter Assay. HT-29 cells
were plated in 6-well plates, grown to 80%–90% conﬂuence,
and transiently transfected with the plasmids of TOPﬂash
and FOPﬂash, respectively. TOPﬂash has 3 copies of the
Tcf/Lef binding sites in the upstream of a thymidine kinase
(TK) promoter and the ﬁreﬂy luciferase gene. FOPﬂash
has mutated copies of Tcf/Lef sites and is used as control
for measuring nonspeciﬁc activation of the reporter. All
transfections were performed with Lipofectamine and 1.8μg
ofTOPﬂash orFOPﬂash plasmids. Tonormalize transfection
eﬃciency, cells were cotransfected with 0.2μgo ft h ei n t e r n a l
controlreporter encodingRenilla reniformis luciferasedriven
under the TK promoter. After transfection, cells were incu-
bated in medium with or without HS7 (2.5–25μg/mL) for
48 hours and then lysed with reporter lysis buﬀer at harvest.
Luciferase activity was determined by using the Dual-
Luciferase Assay System kit according to the manufacturer’s
protocol. The experiments were performed in triplicate, and
theresultswerereportedasfoldsofinductioncomparedwith
control group after normalization of transfection eﬃciency.
2.8. Immunoﬂuorescence Analysis. For immunoﬂuorescence
analysis, cells were plated in 6-well chamber slides for 24
hours before treatment with 10μg/mL of HS7 for 48 hours.
Afterwards, cells were ﬁxed in 2% paraformaldehyde for
10 minutes at room temperature, permeabilized with 0.1%
Triton X-100 in 0.01M PBS pH 7.4 containing 0.2% bovine
serum albumin, air dried, and rehydrated in PBS. Cells were
then incubated with a rabbit polyclonal antibody against
β-catenin (1:500) diluted in PBS containing 3% bovine
serum albumin for 2 hours at room temperature. Negative
controls were performed by omitting the primary antibody.
After washing with PBS twice for 10 minutes, an antirabbit
IgG PE-conjugated secondary antibody (1:500) diluted in
PBS was added and incubated for 1 hour at room temper-
ature. Cells were then washed by PBS and then mounted
using Vectashield mounting medium with 4 ,6-diamidino-
2-phenylindole (DAPI) to counterstain DNA. Cells were
observed using a Zeiss Axiophot ﬂuorescence microscope.
Microphotographs were acquired using an AxioCam MRc
digital video camera and an Axiovision Zeiss software (Carl
Zeiss, Inc., Jena, Germany).
2.9. Preparation of Nuclear Extracts. To obtain nuclear
extracts lysates, the HS7-treated and -untreated cells were
washed twice with ice-cold 1 × PBS and lysed using NE-
PER nuclear extraction reagents. The protein concentrations
of all the extracts were determined by the bicinchoninic
acid protein assay (Pierce, Rockford, IL) with bovine serum
albumin as the standard. Nuclear extracts were stored at
−70◦Cu n t i lu s e d .
2.10. Electrophoretic Mobility Shift Assay (EMSA). Two to
ﬁve μg of nuclear extract was used for EMSA according to
the manufacturer’s instructions. Nuclear extracts containing
equal amounts of protein for each sample were incu-
bated with poly (dI-dC) (1μg/μL) for 5 minutes, followed
by the addition of binding buﬀer and biotinylated oligo
(10ng/μL). After electrophoresis, gels were transferred to
nylon membranes. Transferred oligos were immobilized by4 Evidence-Based Complementary and Alternative Medicine
UVcrosslinkingfor3minutes.Fordetectionofboundoligos,
membranes were blocked using blocking buﬀer followed by
the addition of Streptavidin-HRP, and blots were developed
by ECL according to the manufacturer’s instructions. Com-
mercially available biotinylated oligonucleotideencoding the
Tcf/Lef motif 5 -CCTTTGATCTTCCTTTGATCTT-3  was
used as a canonical probe (Panomics, AY-11149P).
2.11. RNA Extraction and RT-PCR. The expression lev-
els of survivin, c-myc, cyclinD1, MMP7,a n dMT1-MMP
were quantiﬁed by semiquantitative reverse transcription-
polymerasechain reaction (RT-PCR)analysis, using GAPDH
mRNA as an internal standard. HT29 cells (1 × 106 in
10mL medium) were plated in 100mm tissue culturedishes.
After plating for 24 hours, HT29 cells were treated with
diﬀerent doses of HS7 for 48h. At harvest, cellular RNA was
extracted with a TRIzol RNA isolation kit as described in
the manufacturer’s manual. RNA concentration and purity
were determined based on measurement of the absorbance
at 260nm and 280nm. After adding RNase inhibitor (20U),
the total RNA was stored at −70◦C. The sense and antisense
primer sequences used were as follows:
survivin:5  -ATGGGTGCCCCGACGTTGC-3 ,5  -
TCAATCCATGGCAGCCAGCTG-3 ;
c-Myc:5  -CGAGCTGCTGGGAGGAGACAT-3 ,5  -
AGCCGCCCACTTTTGACAGG-3 ;
cyclinD1:5  -CTACAGGGGAGTTTTGTTGA-3 ,5  -
GGTAGTAGGACAGGAAGTTG-3 ;
MMP7:5  -CCTACAGGATCGTATCATAT-3 ,5  -
GGAACAGTGCTTATCAATTC-3 ;
MT1-MMP:5  -TCGGCCCAAAGCAGCAGCTTC-3 ,5  -
CTTCATGGTGTCTGCATCAGC-3 ;
GADPH:5  -CAAAAGGGTCATCATCTCTGC-3 ,5  -
GAGGGGCCACACAGTCTTC-3 ,
respectively. From each sample, 250ng of RNA was reverse-
transcribed, using 200U of SuperScript II RNase-H reverse
transcriptase, 20U of RNase inhibitor, 0.6mM of dNTP,
and 0.5mg/mL of oligo (dT). PCR analyses then were
performed on the aliquots of the cDNA preparations to
detect survivin, c-Myc, cyclinD1, MMP7, MT1-MMP,a n d
GAPDH (as aninternalstandard) genesexpression, using the
FailSafe PCR system (EpicenterTechnologies, Madison, WI).
The reactions took place in a volume of 50μL, containing
a ﬁnal concentration of 50mmol/L Tris-HCl, (pH 8.3),
50mmol/L KCl, 1.5mmol/L MnCl2, 0.2mmol/L dNTP, 2U
ofTaqDNApolymerase,and50pmolofprimers.Afterinitial
denaturationfor2minutesat95◦C,26cyclesofampliﬁcation
(at 95◦Cf o r1m i n ,6 0 ◦Cf o r1m i n ,a n d7 2 ◦Cf o r1 . 5m i n )
were performed, followed by a 7-minute extension at 72◦C.
2.12. Analysis of PCR Products. A1 0μL aliquot from each
PCR reaction was electrophoresed in a 1.8% agarose gel
containing 0.2mg/mL ethidium bromide. The expression
level of survivin was normalized by the corresponding
GAPDH signal from the same gel and expressed as the ratio
of survivin/GAPDH.
2.13. Western Blotting. At harvest, the HS7-treated and
-untreated cells were washed twice with PBS (pH 7.0),
and the total proteins were extracted by adding 200μLo f
cold lysis buﬀer to the cell pellets on ice for 30 minutes.
This was followed by centrifugation at 10,000×gf o r3 0
minutes at 4◦C. Western blotting was performed according
to the method of Yeh and Yen [21]. The membrane was
further incubated overnight at 4◦C with respective speciﬁc
antibodies against caspase-3 (1:1000), PARP (1:1000), Bcl-
2 (1:1000), Bax (1:1000), active β-catenin (1:1000), Tcf-
4 (1:1000), survivin (1:1000), and β-actin (1:5000). After
incubation with primary antibodies, the membrane was
washed with TBST 3 times. The membrane was then incu-
bated with horseradish peroxidase-labeled secondary anti-
body for 45 minutes at room temperature and washed with
TBST 3 times. Final detection was performed with enhanced
chemiluminescence (ECL) Western blotting reagents.
2.14. Statistical Analysis. Each experiment was performed in
triplicate and repeated 3 times. The results were expressed
as means ± SD. The signiﬁcance of diﬀerences between
HS7-treated and vehicle-treated control groups was analyzed
by t-test as appropriate. “∗” indicates that the values are
signiﬁcantlydiﬀerentfromthecontrol(∗P<. 05; ∗∗P<. 01).
3.Results
3.1. Growth Inhibition and Apoptosis Induction of Human
Colon Cancer Cells by HS7 Fraction from T. camphoratus.
The growth inhibitions of human colon cancer cells by HS7
were shown in Figure 1. HS7 had signiﬁcant antiproliferative
eﬀects on HT-29, HCT-116, and SW-480 cells in a dose- and
time-dependent manner. After 48h incubation, the growth
inhibition was most noticeable in HT-29 cells with IC50 of
9.5μg/mL. In contrast, the IC50 for HT-116 and SW-480
cells were 15.1 and 19.4μg/mL, respectively. As shown in
Figure 2, HS7 increased the apoptosis in a dose-dependent
manner in HT29, HCT116, and SW480 cells, including
both the early apoptosis (Annexin V-FITC+/PI−)a n dt h e
late apoptosis (Annexin V-FITC+/PI+). At concentration of
25μg/mL for 48h, the amount of annexin V-FITC-positive
cells were 68.7 ± 1.1%, 39.6 ± 1.2%, and 33.5 ± 1.7% in
HT29, HCT116, and SW480 cells, respectively, compared
to control (less than 0.2%). In addition, it was noted that
there was a remarkable dose-dependent accumulation of
subG1 peak in HS7-treated HT29 cells when compared with
the untreated group (Figure 3(a)). Furthermore, agarose-gel
electrophoresis of HS7-treated chromosomal DNA showed a
ladder-like pattern of DNA fragments in a time- and dose-
dependent manner (Figure 3(b)). Our results suggested that
the apoptosis induction by HS7 might play a substantial role
on the growth inhibition of HT29 cells.
Since HS7 induced signiﬁcant apoptosis in HT29 cells,
we subsequently studied the cellular proteins involved in
apoptosis induction. The Bcl-2 and Bax, two important
members of the Bcl-2 family involved in the mitochondrial
apoptosis pathway, and the downstream elements caspase-
3a n dP A R Pw e r ee x a m i n e d .I nH T 2 9c e l l s ,a ss h o w ni n
Figure 4(a), HS7 caused a signiﬁcant upregulation of BaxEvidence-Based Complementary and Alternative Medicine 5
HS7 (μg/mL)
C
e
l
l
u
l
a
r
v
i
a
b
i
l
i
t
y
(
%
)
HT29
0 10 20 30 40 50
0
20
40
60
80
100
120
(a)
HCT116
HS7 (μg/mL)
C
e
l
l
u
l
a
r
v
i
a
b
i
l
i
t
y
(
%
)
0 1 02 03 04 05 0
0
20
40
60
80
100
120
(b)
24h
48h
SW480
HS7 (μg/mL)
C
e
l
l
u
l
a
r
v
i
a
b
i
l
i
t
y
(
%
)
0
0
10 20 30 40 50
20
40
60
80
100
120
(c)
Figure 1: HS7 inhibited coloncancer cell proliferation in a dose-andtime-dependent mannerin 3 cell lines:(a) HT29,(b) HCT116, and(c)
SW480. Cells were treated with HS7 at a ﬁnal concentration of 0–50μg/mL for 24h and 48h (the control group was treated with DMSO at
concentration of <0.05%). Cell proliferation was determined by SRB assay. Results for the means of cell proliferation (%) ± SD of triplicate
measurements are shown (∗P<. 01 compared with control).
and downregulation of Bcl-2 protein levels, leading to dose-
dependent increase of the Bax/Bcl-2 ratio. Furthermore, the
dose-dependent increased fragments of 17/19kDa caspase-
3 and 85kDa-cleaved PARP further conﬁrmed the apopto-
sis induction (Figure 4(b)). These results suggest that the
mitochondria-dependent pathway may participate in the
HS7-induced apoptosis of HT29 cells.
3.2. HS7 Inhibits β-Catenin/Tcf Pathway in Human Colon
Cancer Cells. To elucidate the role of HS7 on the dysregu-
lated Wnt/β-catenin of colorectal cancer cells, we examined
the activity of β-catenin/Tcf pathway in HS7-treated cells.
The HT29, HCT116, and SW480 cells, having a constitu-
tively active transcriptional activity of β-catenin/Tcf, were
transiently transfected with the reporter plasmid TOPﬂash
or FOPﬂash. The transfection eﬃciency was normalized by
the cotransfected Renilla expression vector. As shown in
Figure 5, HS7 dose-dependently reduced the Tcf-dependent
luciferase activity (TOPﬂash) of all 3 colon cancer cells after
48h of treatment, while the FOPﬂash activity, a mutant of
β-catenin/Tcf binding, remained unchanged. In HT29 cells,
the Tcf transcriptional activities were reduced to 54 ± 3%,
39 ± 4%, 22 ± 2%, and 14 ± 2% of the control by HS7
at dose of 2.5μg/mL, 5μg/mL, 10μg/mL, and 25μg/mL,
respectively. This indicates that the transcriptional activity of6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: HS7 induced apoptosis in human colon cancer cells. (a) SW480,HCT116, and HT29 cells were treated with a range of HS7 (0, 10,
and 25μg/mL) for 48h. Cells then were stained with annexin V/propidium iodide (PI) and analyzed by ﬂow cytometry. Apoptotic cells were
localized in the lower right (early apoptosis) and upper right (late apoptosis) quadrants of the dot-plot graph using annexin V versus PI. (b)
Bar graphs represent the mean values of triplicate measurements ± SD. ∗P<. 05; ∗∗P<. 01, compared with control.Evidence-Based Complementary and Alternative Medicine 7
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Figure 3: Apoptosis induced by HS7 in HT29 cells. (a) HS7 increased the subG1 population in HT29 cells. HT29 cells were grown in the
absence (control) or presence ofHS7 (2.5–25μg/mL) for 48h, stained with propidium iodide (PI),and analyzed by ﬂow cytometry for DNA
content.Arrows indicatepredicted locationoffragmentedDNA orsubG1 population.(b) DNA fragmentationofHT29cells exposed to HS7
is shown. Genomic DNA was extracted from HS7-treated HT29 cells and separated on 1.8% agarose gels.
β-catenin/Tcf could be inhibited by HS7 and thus suppresses
the Wnt/β-catenin signaling pathway.
Binding to its DNA response element is the most
important step for the biological function of transcription
factor. Therefore, we performed electrophoretic mobility
shift assay (EMSA) to investigate whether the inhibitory
eﬀect of HS7 on the transcriptional activity of β-catenin/Tcf
complexwas caused by thedisruptionofitsDNAbinding. In
HT29 cells, Tcf complexes had substantial binding activity
to its DNA response elements. After 48h treatment, such
binding was decreased by HS7 in a dose-dependent manner
(Figure 6(a)) .A tt h es a m ed o s er a n g e ,t h ea c t i v eβ-catenin,
Tcf-4, and inactived/phosphorylated GSK3α/β protein levels
were markedly decreased (Figure 6(b)), which would result
in the reduced binding of β-catenin/Tcf complex to its DNA
response elements.
To determine whether the HS7 suppressed β-catenin-
mediated transcription accompanied with decreasing the
nuclear β-catenin translocation, we investigated the β-
catenin subcellular localization in HS7-treated HT29 cells
by indirect immunoﬂuorescence staining. As shown in
Figure 7(a),t h eβ-catenin was present in all cellular local-
izations and preferentially accumulated in the nucleus in
the control cells, which was conﬁrmed by DAPI staining
(Figure 7(b)). In contrast, after treatment with HS7 at dose
of 10μg/mL for 48h, the localization of β-catenin decreased
at nuclei but increased at cell-cell contacts (Figures 7(c) and
7(d)).
3.3. HS7 Suppresses the Expression of β-Catenin/Tcf Pathway
Downstream Target Genes. Since survivin, c-Myc, cyclin D1,
matrix metalloproteinase-7 (MMP7), and membrane type
I MMP (MT1-MMP) are the downstream target genes of
β-catenin/Tcf pathway, we examined whether HS7 could
downregulate the expressions of those genes in HT29
cells. At the dose of 2.5–10μg/mL, HS7 was able to
inhibit survivin mRNA expression in a dose-dependent
manner (Figure 8(a)). Similarly, after 48h of treatment
with 10μg/mL HS7, the expressions of c-Myc, cyclin D1,8 Evidence-Based Complementary and Alternative Medicine
HS7 (μg/mL)
25
HS7 (μg/mL)
C 2.5 5 10
Bcl-2
Bax
β-actin
B
a
x
/
B
c
l
-
2
r
a
t
i
o
0
0
3
6
9
12
25 2.5 5 10
(a)
25
HS7 (μg/mL)
C 2.5 5 10
Procaspase-3 (30kDa)
Caspase-3 (17/19kDa)
PARP
Cleaved PARP
β-actin
(b)
Figure 4: HS7 regulated expression of speciﬁc proteins in HT29
cells involved in apoptosis. (a) Protein expression of Bax and Bcl-2
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by Western blot. Relative changes in Bcl-2 and Bax protein bands
were measured using densitometric analysis. (b) HS7 induced
caspase-3activation andcleavedPARP in HT29 cells. Typicalresults
from 3 independent experiments were shown.
MMP7,a n dMT1-MMP were also signiﬁcantly downregu-
lated (Figure 8(b)).
The hypothetical diaphragm describing the molecular
mechanisms responsible for anticancer eﬀects of HS7 on
colon cancer cell was illustrated in Figure 9.
4.Discussion
The induction of apoptosis by crude extract of T. camphor-
atus had been reported in several types of cancer cells such
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representative of two independent experiments.
as prostate cancer and hepatoma cells [22, 23]. Its eﬀects on
the apoptosis modulating proteins, such as Bcl-2, Bax, and
Bid, had been demonstrated in Hep 3B hepatoma cells [23].
In accordance with those studies, our data also showed the
increased Bax/Bcl-2 ratio, activated Caspase-3, and cleaved
PARP in HS7-treated HT-29 colon cancer cells. The T.
camphoratus-induced apoptosis was signiﬁcant in wild-type
p53 expressing prostate cancer cells LNCaP but limited in
null p53 prostate cancer cells PC3 [22]. However, in our
data,HS7inducedsigniﬁcantapoptosisnotonlyinwild-type
p53 expressing HCT116 cells but also in p53 mutant HT29
and SW480 cells. The correlation of p53 defective status
with apoptosis induced by T. camphoratus may need further
investigation.
Many natural triterpenes had been reported able to
induceapoptosis incancercells. Based onourpreviousstudy
in SW480 and HT-29 colon cancer cells, several triterpenes
isolated from T. camphoratus also exerted the apoptosis
inducing eﬀects [24]. To date, two known phytochemicals
a r ep r e s e n ti nt h ea c t i v ef r a c t i o nH S 7e x t r a c t e df r o mT.
camphoratus. One is 15-α-acetyl-dehydrosulphurenic acid
[25] and another is antroquinonol [26]. In addition, we had
isolated a novel compound named P7b from HS7, which is
more potent than antroquinonol in anticancer activities. The
identiﬁcation of the chemical structure of P7b is ongoing
now.
In this study, we also demonstrated the inhibitory eﬀects
of HS7 on the Wnt/β-catenin signaling pathway of HT-
29 colon cancer cells. Based on the EMSA and luciferase
reporter assays, both the DNA binding and the transcription
activity of β-catenin/Tcf complex were eﬀectively inhibited
by HS7. These eﬀects were further conﬁrmed by the
suppressed expression of β-catenin/Tcf downstream target
genes, such as survivin, c-Myc, cyclin D1, MMP7,a n dMT1-
MMP in HS7-treated HT-29 cells. This inhibition of Wnt/β-
catenin signaling pathway may result from the decreased
nuclear translocation of β-catenin and the downregulated
protein levels of both Tcf-4 and active β-catenin. This is
the ﬁrst study demonstrating the inhibitory eﬀects of T.
camphoratus on the Wnt/β-catenin signaling pathway of
colon cancer cells.
The level of β-catenin in cells is tightly controlled by
its degradation complex composed of Axin, APC, GSK-
3β,a n dβ-catenin, in which GSK-3β phosphorylates β-
catenin and thus triggers its ubiquitination and subsequent
proteasomal degradation. As β-catenin negative regulator
GSK3β is inactivated by phosphorylation, the HS7-induced
decrease of p-GSK3β might contribute to its eﬀects on
Wnt/β-catenin pathwayinhibition.Takentogether,theabove
ﬁndings provide evidence for GSK-3β dephosphorylation
in HS7-induced degradation of β-catenin in colon cancer
cells.
Severalgenesactivated bydysregulated β-catenin, suchas
c-myc and survivin, are regarded as apoptosis regulators. The
β-catenin has become further implicated in the regulation of
apoptosis recently. Steinhusen et al. reported the apoptosis-
induced cleavage of β-catenin by caspase-3; however, they
proposed that the proteolytic cleavage of β-catenin might
not be simply an eﬀect of apoptosis [27]. More recently, the
caspase-mediated cleavage of β-catenin was demonstrated
to precede drug-induced apoptosis in resistant cancer cells,
indicating the potential of β-catenin as a promising new
target of drug-induced apoptosis [28]. In our results, HS7
markedly inhibited the β-catenin/Tcf-dependent luciferase
activity at dose of 5μg/mL, whereas the caspase-3 was10 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Eﬀect of HS7 on cellular localization of β-catenin in HT-29 cells was shown. Cellular localization of β-catenin was evaluated by
indirect immunoﬂuorescenceusingamonoclonalantibody thatlabeled β-catenin. Immunoﬂuorescencelabeling ofβ-catenin in cells treated
with vehicle (a) or 10μg/mL HS7 (c) for 48h were shown (red). Nuclei in cells treated with vehicle (b) or 10μg/mL HS7 (d) for 48h were
counterstained with 4 , 6-diamidino-2-phenylindole (blue). Merged images show that the β-catenin protein located at cell-cell contacts in
HS7-treated cells was signiﬁcantly increased as compared to control (e and f). Magniﬁcation for each representative picture: 200x (from 3
separate experiments).
markedly cleaved and activated at 25μg/mL. The inhibition
of Wnt/β-catenin signaling pathway might be an important
part of HS7-induced apoptosis pathway rather than just a
downstream eﬀectofapoptosis. Similarly,ourresultsshowed
that β-catenin protein mainly located at cell-cell contacts
after treatment with HS7 (10μg/mL) in colon cancer cells.
The nuclear staining of β-catenin was markedly reduced
as compared with that in control group. Therefore, this
inhibitionofβ-catenin-induced transcription mightresultin
the apoptosis of colon cancer cells.
Aspirin and other nonsteroidal anti-inﬂammatory drugs
(NSAIDs), being used as chemopreventive agents against
CRC, had been found to inhibit the Wnt/β-catenin signaling
pathway[11].Bothaspirin and indomethacincoulddecrease
thetranscriptional activityofβ-catenin/Tcf-responsive genes
[29]. Sulindac is able to suppress the nuclear β-catenin
localization and β-catenin/Tcf-regulated genes [30]. Cele-
coxib, the only one NSAID approved by Food and Drug
Administration in the USA for the treatment of familial
adenomatous polyposis (FAP), was also found to inhibit the
Wnt/β-catenin signaling pathway in colon cancer cells [31].
However, most NSAIDs except celecoxib may cause adverse
eﬀects such as bleeding and the gastric mucosa damage due
to their more eﬀects on COX-1 inhibition. Nevertheless,
the celecoxib had side eﬀects on the risk of cardiovascular
diseases [32]. Thus, searching for alternative agents other
than NSAIDs is needed for the prevention and treatment of
CRC.
Regarding the profound suppressing eﬀects on the
Wnt/β-catenin pathway of colon cancer cells, HS7 may serve
as an alternative CRC preventing dietary supplement in
addition to NSAIDs. Similar to HS7, other natural dietary
substances such as epigallocatechin-3-gallate (EGCG), cur-
cumin, and resveratrol had also been demonstrated to exert
activities on Wnt/β-catenin pathway inhibition [33–35].
Combined use of these active natural substances may have
synergistic eﬀects and become a good strategy to achieve
better clinical eﬀectiveness. Therefore, further preclinical
studies on such combinations are warranted.
Wnt/β-catenin signaling also appears to regulate cancer
cell invasion, metastasis, and angiogenesis [36]. Holcombe
et al. had demonstrated that the expression of Wnt fam-
ily ligands correlated with the invasion of colon cancer
[37]. Recently, Brabletz et al. reported that β-catenin/Tcf-
regulated genes, such as MMP7 and MT1-MMP, were
involved in the regulation of cell growth, invasion, and
angiogenesis of colorectal cancer [38, 39]. In particular,
MMP-7 has been shown to be overexpressed in 75% of
human colorectal cancers and correlate with stages of
disease and/or prognosis [40]. Similarly, MT1-MMP is
overexpressed in diﬀerent tumors, including colon cancer
and correlates with the invasiveness and metastasis [41].Evidence-Based Complementary and Alternative Medicine 11
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Furthermore, Peng et al. demonstrated that T. camphoratus
suppressed the active MMP-9 levels correlated with the
inhibition of transwell motili t yo fT 2 4b l a d d e rc a n c e rc e l l s
[42]. Regarding the substantial inhibitory eﬀects of HS7 on
Wnt/β-catenin signaling and its downstream MMP7 and
MT1-MMP mRNAs expression, it indicates the potential use
of HS7 as anti-invasion and antiangiogenesis agent against
colon cancer cells.
T h ei m p o r t a n c eo fW n t / β-catenin signaling is also
highlighted in modulating stemness, proliferation, and dif-
ferentiation in several adult stem cell niches, such as hair fol-
licles, mammary gland, intestinal crypt, and hematopoietic
tissues [43]. In addition, the Wnt/β-catenin signaling also
plays an important role in cancer stem cells [44]. Expression
of stabilized β-catenin promotes the self-renewal of hepatic
stem/progenitor cells and leads to tumorigenesis in the liver
[45]. Recently, we have successfully isolated cancer stem-like
side population (SP) cells from Huh 7 hepatoma cell line
and found that HS7 could reduce the proportion of these
SPcells accompaniedwithdownregulation ofWnt/β-catenin
signaling and thereby suppressing the tumorigenicity of SP
cells on NOD/SCID mice (data not shown), indicating that
HS7 may have eﬀectson the elimination of cancer stem cells.
In addition to the remarkable eﬀects of HS7 on apop-
tosis induction and inhibition of Wnt/β-catenin signaling
pathway, further investigations to explore its eﬀects on other12 Evidence-Based Complementary and Alternative Medicine
APC
Axin
Wnt
Membrane
Dsh
GSK3 β
Frizzle
Tcf/Lef
Nucleus
Gene transcription
Bax Bcl-2
Mitochondria
Caspase-3
Cleavage of
PARP
Apoptosis
Promote
Repress
β-catenin
β-catenin
β-catenin
HS7
Survivin
MMP7
MT1-MMP
c-Myc
Figure 9: Hypothetical diaphragm of HS7 induced apoptosis and
inhibition of Wnt/β-catenin signaling pathway in HT-29 colon
cancer cells. The arrow indicates promotion, and the T-shaped bar
indicates repression. Dsh: dishevelled protein, GSK-3β:g l y c o g e n
synthase kinase-3 beta, APC: adenomatous polyposis coli protein,
Tcf/Lef: T-cell factor/lymphocyte enhancer factor family, PARP:
poly (ADP-ribose) polymerase.
s i g n a l i n gp a t h w a y sa sw e l la st h ea s p e c t so fa n t i a n g i o g e n e s i s ,
anti-invasion, and elimination of cancer stem cells are
strongly recommended. The eﬀects of HS7 shown in this
study may provide important insight for the use of T.
camphoratus as a potential complementary and integrated
medicine for the treatment of colorectal cancer.
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